10.1038/s41467-023-35961-y - Candidate mechanisms of acquired resi...

This document has been corrected

Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer

10.1038/s41467-023-35961-y

Published Online: 2023-02-27

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Aleksandra Markovets•Alexander Todd•Byoung Chul Cho•Fumio Imamura•J. Carl Barrett•Jhanelle E. Gray•Juliann Chmielecki•Margarita Majem•Meng-Chih Lin•Riyaz Shah•Ryan J. Hartmaier•Suresh S. Ramalingam•Ying Cheng•Yuichiro Ohe•Yuri Rukazenkov

This document has been corrected

Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer

10.1038/s41467-023-35961-y

Published Online: 2023-02-27

Journal: Nature Communications

NOW

2023-06-01•Correction

Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer

10.1038/s41467-023-38999-0

* information provided by CrossRef

2023-06-01•Correction

10.1038/s41467-023-38999-0

* information provided by CrossRef

2023-02-27•Published

2023-06-01•Correction

Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer

10.1038/s41467-023-38999-0

* information provided by CrossRef

This document has been corrected

Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer

10.1038/s41467-023-35961-y

Published Online: 2023-02-27

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC